Chinese Export Surge Clouds U.S. Hopes of a Domestic Solar Boom
The decision by a Massachusetts solar company to abandon plans to build a $1.4 billion U.S. factory highlights the risks amid a flood of Chinese clean energy exports.
By
The decision by a Massachusetts solar company to abandon plans to build a $1.4 billion U.S. factory highlights the risks amid a flood of Chinese clean energy exports.
By
From cars to solar panels to furniture, China is using lavish bank lending and enormous investments in robotics to cement its global leadership in manufacturing.
By
A federal auto safety agency said the accelerator pedal on the pickup truck, sales of which began in late 2023, could become stuck, increasing the risk of accidents.
By
A rally at the start of the year has given way to worries on Wall Street about economics and geopolitics.
By
Inflation, Interest Rates and Oil Prices Have Jolted the Markets
Euphoria has been replaced by a much more somber mood, changing the value calculations in a host of markets, our columnist says.
By
Zaslav Receives $50 Million for Leading Struggling Warner Bros. Discovery
The chief executive’s 2023 pay package rose 26 percent from the year before, while the company’s losses totaled $3 billion.
By
What to Do When Your 401(k) Leaves Something to Be Desired
Over the course of a career, the high fees and a lower-quality menu of investment options found in some plans can shrink your balance significantly.
By
Thousands Are Eligible for Tax Refunds From 2020
The I.R.S. estimates that 940,000 people who didn’t file their returns for that year are due back money. The deadline for filing to get it is May 17.
By
Apple Says It Was Ordered to Pull WhatsApp From China App Store
Apple said it removed WhatsApp and Threads from its China app offerings Friday on Beijing’s orders, amid technological tensions between the U.S. and China.
By Tripp Mickle and
Advertisement
Ozempic and Wegovy, the diabetes and weight-loss drugs, have soared to celebrity status in the U.S. But Novo Nordisk, the Danish company behind them, can’t make enough of them. The New York Times reporter Eshe Nelson went to the drugmaker’s headquarters to see how the company is transforming to deal with the global fame and demand.
By Nikolay Nikolov, Eshe Nelson and Charlotte de la Fuente
In Kalundborg, population under 17,000, Novo Nordisk is making huge investments to increase production of its popular diabetes and weight-loss drugs, Ozempic and Wegovy.
By Eshe Nelson
Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions.
By Eshe Nelson and Charlotte de la Fuente
The Volkswagen plant in Chattanooga is set to become the first unionized auto factory in the South not owned by one of Detroit’s Big Three.
By Neal E. Boudette
Testing for H5N1 infection has been limited, and the outbreak was never confined. But asymptomatic cows in North Carolina may require a reassessment.
By Apoorva Mandavilli and Emily Anthes
Journalists covering the trial face a tricky balancing act: inform the public while keeping its participants out of harm’s way.
By Tiffany Hsu
Mr. Walsh won a Pulitzer Prize for investigative reporting in 1969 and later joined The New York Times, which eventually fired him.
By Michael S. Rosenwald
The agency announced new rules to address the dangers of exhaustion for controllers, who often work grueling round-the-clock schedules.
By Sydney Ember
His serial frauds included a waterfront development in Buffalo, a civil rights law firm in California and a package delivery company in Springfield, Ill.
By Richard Sandomir
Manish Lachwani, who founded the software start-up HeadSpin, is the latest tech entrepreneur to face time in prison in recent years.
By Erin Griffith
Advertisement
Advertisement